| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $49.9M | +15.2% |
| Cost of Revenue | $31.0M | +21.0% |
| Gross Profit | $18.9M | +6.9% |
| R&D Expense | $330K | +188.9% |
| SG&A Expense | $10.2M | +10.0% |
| Operating Income | -$3.4M | -57.1% |
| Pre-tax Income | -$3.2M | -83.6% |
| Income Tax | $21K | -65.6% |
| Net Income | -$3.3M | -78.7% |
| EPS (Basic) | -$0.31 | -72.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.1M | -38.8% |
| Accounts Receivable | $3.9M | +121.2% |
| Inventory | $7.8M | +30.2% |
| Current Assets | $18.8M | +4.9% |
| Total Assets | $19.2M | -0.2% |
| Current Liabilities | $7.7M | +30.2% |
| Total Liabilities | $7.8M | +27.9% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.8M | -421.8% |
| Capital Expenditures | $76K | +208.6% |
| Investing Cash Flow | -$76K | -208.6% |
| Financing Cash Flow | -$332K | -893.7% |
| Free Cash Flow | -$2.9M | -440.4% |
| $11.5M |
| -13.1% |